๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells

โœ Scribed by Kohji Takara; Megumi Fujita; Tetsuya Minegaki; Kazuhiro Yamamoto; Minoru Takahashi; Teruyoshi Yokoyama; Katsuhiko Okumura

Book ID
113592567
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
744 KB
Volume
45
Category
Article
ISSN
0928-0987

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

5-fluorouracil and interferon-alpha-2a i
5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules
โœ William J. John; John R. Neefe; John S. Macdonald; Jim Cantrell Jr.; Marietta Sm ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 505 KB

Background. Potential synergy between 5-fluorouracil (5-FU) and interferon alpha-2a (IFN-a-Za) has been demonstrated in the treatment of colorectal carcinoma. Continuous low-dose infusion of 5-FU may have superior response rates to bolus 5-FU in these malignancies. This report presents results of tw

Schedule-dependent in vitro combination
Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines
โœ Chun-Ming Tsai; Adi F. Gazdar; Reury-Perng Perng; Barnett S. Kramer ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 702 KB

Because of conflicting reports of clinical synergy, we used the tetrazolium-based colorimetric (MTT) assay to test in vitro combination effects of methotrexate (MTX) plus 5fluorouracil (FUra) in 4 schedules on 2 human non-small-cell lung cancer cell lines (adenocarcinoma, NCLH23; bronchioalveolar-ce